Floatz logo

6 assets in Pediatric Multiple Sclerosis

Therapeutic assets addressing Pediatric Multiple Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Jnj-78436735
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Moderna Covid-19 Vaccine Rna
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Monovalent [B.1.351] Cov2 Pres Dtm-As03
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Methotrexate
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (52)
Tozinameran
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (50)
bnt162b2
Pediatric Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CC (43)